Development and validation of the Montreal Cognitive Assessment for People with Vision Impairment (MOCA-VI).
Piers Dawes(The University of Queensland), Iracema Leroi(Trinity College Dublin), Annie Pye(Manchester Academic Health Science Centre), Ziad Nasreddine(Université de Sherbrooke), Saima Sheikh(Imperial College London), Catherine Helmer(Inserm), Hamid R. Sohrabi(Murdoch University), Wai Kent Yeung(University of Manchester), Anna Pavlina Charalambous(European University Cyprus), David Reeves(Manchester Academic Health Science Centre), Chryssoula Thodi(European University Cyprus), Sheela Kumaran(UNSW Sydney), Gail Robinson(Allen Institute for Brain Science), Ralph N. Martins(Edith Cowan University), Fiona Holland(Manchester Academic Health Science Centre), Lisa Keay(UNSW Sydney), Renaud David(Centre Hospitalier Universitaire de Nice), Kathleen Gallant, Gregor Russell(Bradford District Care NHS Foundation Trust), Antonis Politis(National and Kapodistrian University of Athens), Marianne Piano(Australian College of Optometry), Rebecca E Leighton(University of Ulster), Julie‐Anne Little(University of Ulster)
Cited by 6
Related Papers
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
|Nature Medicine|2019|948
The changing prevalence and incidence of dementia over time — current evidence
|Nature Reviews Neurology|2017|773